Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,794.00
Bid: 6,778.00
Ask: 6,780.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.03%)
Open: 6,886.00
High: 6,919.00
Low: 6,736.00
Yest. Close: 6,880.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca steps up push into cancer immunotherapy

By Ben Hirschler LONDON, July 31 (Reuters) - AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumour types. The company is seen as No. 4 in a race to develop the first drug in a new class that fights cancer by unleashing

31 Jul 14 12:51

London midday: Earnings come in mixed as investors watch US data, Fed

- Shell, BG Group and Intu lead the risers - Weir, Schroders and Lloyds fall - Afren drops after suspending directors - US data and Fed keep investors cautious techMARK 2,763.54 -0.57% FTSE 100 6,763.04 -0.15% FTSE 250 15,495.73 -0.86% London stocks were trading in the red for a second straight da

31 Jul 14 12:04

UPDATE 3-AstraZeneca raises forecasts after seeing off Pfizer

* One-off payments and tax benefit flatter Q2 results * Investors focused on possible Pfizer return * Q2 revenue $6.45 billion vs consensus $6.29 billion * Q2 core EPS $1.30 vs consensus $1.10 * Now assuming generic Nexium in U.S. from Oct. 1 (Adds CEO comments from conf

31 Jul 14 10:45

TOP NEWS: Strong Results From Shell Highlight UK Corporate Earnings

31 Jul 14 10:32

UPDATE: AstraZeneca Raises Guidance Despite Interim Profit Fall

31 Jul 14 09:54

Astrazeneca raises guidance after better-than-expected Q2

- Core EPS and revenue outlook raised - H1 revenue up 3%, Q2 revenue up 4% - Q2 PBT of $1.89bn Astrazeneca has lifted its guidance for the year after delivering a 4% increase in second quarter revenue to $6.4bn, ahead of expectations. Half year turnover at the drugs giant climbed 3%, driven by ga

31 Jul 14 08:42

UPDATE 2-AstraZeneca raises forecasts after seeing off Pfizer

* One-off payments and tax benefit flatter Q2 results * Investors focused on possible Pfizer return * Q2 revenue $6.45 billion vs consensus $6.29 billion * Q2 core EPS $1.30 vs consensus $1.10 * Now assuming generic Nexium in U.S. from Oct. 1 (Adds analyst comment, share

31 Jul 14 08:06

AstraZeneca Raises Revenue And Earnings Guidance Despite Profit Fall

31 Jul 14 06:47

UPDATE 1-AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

* Q2 revenue $6.45 billion vs consensus $6.29 billion * Q2 core EPS $1.30 vs consensus $1.10 * Drugmaker raises full-year guidance * Now assuming generic Nexium in U.S. from Oct. 1 (Adds detail on products, background) By Ben Hirschler LONDON, July 31 (Reuters) - A

31 Jul 14 06:46

MARKET COMMENT: UK Stocks To Open Higher With Earnings In Focus

31 Jul 14 06:25

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

LONDON, July 31 (Reuters) - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago. Sales in the first quarter rose 4 percent to $6.45 billion, des

31 Jul 14 06:18

UK Earnings, Trading Statements Calendar - Week Ahead

31 Jul 14 05:24

MARKET COMMENT: UK Stocks Fall As US GDP Surge Turns Attention To Fed

30 Jul 14 16:34

UK Earnings, Trading Statements Calendar - Week Ahead

30 Jul 14 15:27

Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials

* Sanofi to file drug for US and EU approval by year-end * Nine Phase III ODYSSEY trials meet primary endpoint * Alirocumab "generally well tolerated" in trials By Natalie Huet PARIS, July 30 (Reuters) - A new drug being developed by French drugmaker Sanofi and U.S. partne

30 Jul 14 12:00

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.